Literature DB >> 30916011

European Society of Anaesthesiology Task Force on Nitrous Oxide: a narrative review of its role in clinical practice.

Wolfgang Buhre1, Nicola Disma2, Jan Hendrickx3, Stefan DeHert4, Markus W Hollmann5, Ragnar Huhn6, Jan Jakobsson7, Peter Nagele8, Philip Peyton9, Laszlo Vutskits10.   

Abstract

Nitrous oxide (N2O) is one of the oldest drugs still in use in medicine. Despite its superior pharmacokinetic properties, controversy remains over its continued use in clinical practice, reflecting in part significant improvements in the pharmacology of other anaesthetic agents and developing awareness of its shortcomings. This narrative review describes current knowledge regarding the clinical use of N2O based on a systematic and critical analysis of the available scientific literature. The pharmacological properties of N2O are reviewed in detail along with current evidence for the indications and contraindications of this drug in specific settings, both in perioperative care and in procedural sedation. Novel potential applications for N2O for the prevention or treatment of chronic pain and depression are also discussed. In view of the available evidence, we recommend that the supply of N2O in hospitals be maintained while encouraging its economic delivery using modern low flow delivery systems. Future research into its potential novel applications in prevention or treatment of chronic conditions should be pursued to better identify its role place in the developing era of precision medicine.
Copyright © 2019 British Journal of Anaesthesia. All rights reserved.

Entities:  

Keywords:  anaesthesia; analgesia; dental pain; labour analgesia; major depression; nitrous oxide; pain; pharmaco-economics

Mesh:

Substances:

Year:  2019        PMID: 30916011     DOI: 10.1016/j.bja.2019.01.023

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

Review 1.  Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review.

Authors:  Sanad Oulkadi; Benjamin Peters; Anne-Sophie Vliegen
Journal:  J Thromb Thrombolysis       Date:  2022-06-27       Impact factor: 2.300

Review 2.  Guidelines for Perioperative Care in Elective Abdominal and Pelvic Surgery at Primary and Secondary Hospitals in Low-Middle-Income Countries (LMIC's): Enhanced Recovery After Surgery (ERAS) Society Recommendation.

Authors:  Ravi Oodit; Bruce M Biccard; Eugenio Panieri; Adrian O Alvarez; Marianna R S Sioson; Salome Maswime; Viju Thomas; Hyla-Louise Kluyts; Carol J Peden; Hans D de Boer; Mary Brindle; Nader K Francis; Gregg Nelson; Ulf O Gustafsson; Olle Ljungqvist
Journal:  World J Surg       Date:  2022-05-31       Impact factor: 3.282

3.  Virtual reality vs. Kalinox® for management of pain in intensive care unit after cardiac surgery: a randomized study.

Authors:  Driss Laghlam; Cecile Naudin; Lucas Coroyer; Vincent Aidan; Julien Malvy; Ghilas Rahoual; Philippe Estagnasié; Pierre Squara
Journal:  Ann Intensive Care       Date:  2021-05-13       Impact factor: 6.925

4.  Clinical, Electrophysiological and Radiological Features of Nitrous Oxide-Induced Neurological Disorders.

Authors:  Lei Bao; Qing Li; Qingjie Li; Hao Chen; Ruixue Zhang; Hongjuan Shi; Guiyun Cui
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-15       Impact factor: 2.570

5.  Quantitative Assessment of Nitrous Oxide Levels in Room Air of Operation Theaters and Recovery Area: An Observational Study.

Authors:  G D Puri; Shyam C Meena; Vinayak Sinha; Amarjyoti Hazarika; Haseeb Hakkim; Ashish Sharma; Kamal Kajal; Neeti Dogra
Journal:  Indian J Occup Environ Med       Date:  2021-10-09

Review 6.  Current status of nitrous oxide use in pediatric patients.

Authors:  Nishkarsh Gupta; Anju Gupta; Vishnu Narayanan M R
Journal:  World J Clin Pediatr       Date:  2022-03-09

Review 7.  Peripheral polyneuropathy and acute psychosis from chronic nitrous oxide poisoning: A case report with literature review.

Authors:  Radhika Sood; Thibault Parent
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.